Related Experiment Videos

Oral antidiabetic agents safe with renal disease?

¹Department of Preventive Medicine, Rush-Presbyterian-St Luke's Medical Center, Chicago, USA.

Postgraduate Medicine

|July 11, 2000

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies.

Journal of internal medicine·2014

Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease.

Diabetes, obesity & metabolism·2014

Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease.

Diabetes, obesity & metabolism·2013

Effects of combining simvastatin with rosiglitazone on inflammation, oxidant stress and ambulatory blood pressure in patients with the metabolic syndrome: the SIROCO study.

Diabetes, obesity & metabolism·2011

N-terminal prohormone brain natriuretic peptide as a predictor of cardiovascular disease and mortality in blacks with hypertensive kidney disease: the African American Study of Kidney Disease and Hypertension (AASK).

Circulation·2008

Low birth weight is associated with chronic kidney disease only in men.

Kidney international·2007

See all related articles